FDA.reportPublic FDA data

sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]

RxCUI
2626378
RxNorm name
sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]
Display name
sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]
Full name
sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89abc31c-43e8-4809-9eb7-172cb31a86f1OLPRUVA 3 GM Granules for Oral Suspension [PSN] · sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva] [SBD] · Olpruva 3 GM Granules for Oral Suspension [SY]34These highlights do not include all the information needed to use OLPRUVA TM safely and effectively. See full prescribing information for OLPRUVA. OLPRUVA (sodium phenylbutyrate) for oral suspension Initial U.S. Approval: 199620241218